Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.

Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, Qiu W, Qian L, Li B, Zhang YH, Shi GP.

Ann Med. 2013 May;45(3):220-9. doi: 10.3109/07853890.2012.732234. Epub 2012 Oct 30.

2.

Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus.

Wang Z, Zhang H, Shen XH, Jin KL, Ye GF, Qian L, Li B, Zhang YH, Shi GP.

PLoS One. 2011;6(12):e28962. doi: 10.1371/journal.pone.0028962. Epub 2011 Dec 16.

3.

Elevated level of C-reactive protein is associated with risk of prediabetes in Indians.

Jaiswal A, Tabassum R, Podder A, Ghosh S, Tandon N, Bharadwaj D.

Atherosclerosis. 2012 Jun;222(2):495-501. doi: 10.1016/j.atherosclerosis.2012.02.034. Epub 2012 Feb 28.

PMID:
22464286
4.

Cardiovascular risk factors, carotid artery intima media thickness, and HSCRP levels in patients with impaired glucose metabolism.

Karbek B, Cakal E, Cakir E, Bozkurt N, Unsal I, Sahin M, Delibaşi T.

Minerva Endocrinol. 2013 Sep;38(3):297-304.

PMID:
24126550
5.

Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.

Zhang F, Tang X, Cao H, Lü Q, Li N, Liu Y, Zhang X, Zhang Y, Cao M, Wan J, An Z, Tong N.

Int J Med Sci. 2012;9(7):574-81. Epub 2012 Sep 7.

6.

Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).

Chakarova N, Tankova T, Atanassova I, Dakovska L.

Diabetes Res Clin Pract. 2009 Oct;86(1):56-60. doi: 10.1016/j.diabres.2009.04.005. Epub 2009 Aug 11.

PMID:
19674805
7.

Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.

Onat A, Can G, Çiçek G, Ayhan E, Doğan Y, Kaya H.

Acta Diabetol. 2013 Aug;50(4):519-28. doi: 10.1007/s00592-011-0313-x. Epub 2011 Jul 16.

PMID:
21769500
8.

Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.

Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K.

Diabetes Care. 2009 Mar;32(3):439-44. doi: 10.2337/dc08-1195. Epub 2008 Dec 3.

9.

Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.

Chen G, Shi L, Cai L, Lin W, Huang H, Liang J, Li L, Lin L, Tang K, Chen L, Lu J, Bi Y, Wang W, Ning G, Wen J.

Horm Metab Res. 2017 Feb;49(2):135-141. doi: 10.1055/s-0042-111325. Epub 2016 Jul 26.

PMID:
27459384
10.

Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.

PMID:
15977101
11.

Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.

Janghorbani M, Amini M.

Diabetes Res Clin Pract. 2015 Jun;108(3):414-22. doi: 10.1016/j.diabres.2015.03.002. Epub 2015 Mar 13.

PMID:
25814432
12.

Pre-diabetes in Italian obese children and youngsters.

Brufani C, Fintini D, Ciampalini P, Nocerino V, Crea F, Giannone G, Patera PI, Valerio G, Cappa M, Barbetti F.

J Endocrinol Invest. 2011 Oct;34(9):e275-80. doi: 10.3275/7798. Epub 2011 Jun 7.

PMID:
21666412
13.

Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.

Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul-Ghani MA.

Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8.

PMID:
21553243
14.

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.

Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC.

Diabetes. 2000 Jun;49(6):975-80.

PMID:
10866050
15.

Impaired fasting glucose is not a risk factor for atherosclerosis.

Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C.

Diabet Med. 1999 Mar;16(3):212-8.

PMID:
10227566
16.

Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.

Protopsaltis I, Foussas S, Angelidi A, Gritzapis A, Sergentanis TΝ, Matsagos S, Tzirogiannis K, Panoutsopoulos GI, Dimitriadis G, Raptis S, Melidonis A.

Cardiovasc Diabetol. 2012 Nov 15;11:141. doi: 10.1186/1475-2840-11-141.

17.

Insulin secretion and sensitivity in Bangladeshi prediabetic subjects.

Rahman MH, Hafizur RM, Nahar Q, Khan AR, Ali L.

J Diabetes Complications. 2010 Jan-Feb;24(1):37-42. doi: 10.1016/j.jdiacomp.2008.09.003. Epub 2008 Nov 14.

PMID:
19010062
18.

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J.

Diabetes Care. 2006 Aug;29(8):1909-14.

PMID:
16873801
19.

Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism.

Moors CC, van der Zijl NJ, Diamant M, Blaak EE, Goossens GH.

Int J Obes (Lond). 2012 May;36(5):709-17. doi: 10.1038/ijo.2011.123. Epub 2011 Jun 28.

PMID:
21712806
20.

Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.

Miyazaki Y, Akasaka H, Ohnishi H, Saitoh S, DeFronzo RA, Shimamoto K.

Hypertens Res. 2008 Jul;31(7):1357-63. doi: 10.1291/hypres.31.1357.

PMID:
18957806

Supplemental Content

Support Center